Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Fecal Occult Testing
Fecal occult testing is simple and non-invasive in nature, thereby increasing its preference among many physicians. The results of few of the fecal occult tests can be obtained rapidly through point-of-care (POC) test kits such as Alere's Clearview iFOB, and Beckman Coulter's Hemoccult II SENSA. For instance, the Clearview iFOB test is based on human hemoglobin and gastrointestinal bleeding, and can provide results in five minutes. Beckman Coulter's Hemoccult II SENSA slides allow people to collect fecal samples at home settings and send them to hospitals, laboratories, and diagnostic centers.
Technavio’s analysts forecast the global fecal occult testing market to grow at a CAGR of 4.82% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global fecal occult testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fecal occult testing products used to perform colorectal cancer screening.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Fecal Occult Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Beckman Coulter
• Eiken Chemical
• Epigenomics
• Quidel
Other prominent vendors
• Abbott Laboratories
• AccuBioTech
• Applied Proteomics
• ASAN PHARM.
• Assure Tech.
• BIOHIT Healthcare
• EDP Biotech
• FUJIREBIO
• GeneNews
• NanoRepro
• Nantong Egens Biotechnology
• Orion Diagnostica
• Polymedco
• Quest Diagnostics
• Randox
• VolitionRx
Market driver
• Government initiatives and pilot programs worldwide
• For a full, detailed list, view our report
Market challenge
• High cost of FITs and limited reimbursement
• For a full, detailed list, view our report
Market trend
• Direct-to-consumer laboratory testing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Fecal occult testing is simple and non-invasive in nature, thereby increasing its preference among many physicians. The results of few of the fecal occult tests can be obtained rapidly through point-of-care (POC) test kits such as Alere's Clearview iFOB, and Beckman Coulter's Hemoccult II SENSA. For instance, the Clearview iFOB test is based on human hemoglobin and gastrointestinal bleeding, and can provide results in five minutes. Beckman Coulter's Hemoccult II SENSA slides allow people to collect fecal samples at home settings and send them to hospitals, laboratories, and diagnostic centers.
Technavio’s analysts forecast the global fecal occult testing market to grow at a CAGR of 4.82% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global fecal occult testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fecal occult testing products used to perform colorectal cancer screening.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Fecal Occult Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Beckman Coulter
• Eiken Chemical
• Epigenomics
• Quidel
Other prominent vendors
• Abbott Laboratories
• AccuBioTech
• Applied Proteomics
• ASAN PHARM.
• Assure Tech.
• BIOHIT Healthcare
• EDP Biotech
• FUJIREBIO
• GeneNews
• NanoRepro
• Nantong Egens Biotechnology
• Orion Diagnostica
• Polymedco
• Quest Diagnostics
• Randox
• VolitionRx
Market driver
• Government initiatives and pilot programs worldwide
• For a full, detailed list, view our report
Market challenge
• High cost of FITs and limited reimbursement
• For a full, detailed list, view our report
Market trend
• Direct-to-consumer laboratory testing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
